The emerging treatment of the medication represents a major breakthrough in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide981622.dbblog.net/15359241/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment